Validity of the Medication Safety Self-Assessment for Long-Term Care tool in Australian long-term care: a RAND appropriateness method study.

IF 3.1 3区医学 Q2 PHARMACOLOGY & PHARMACY

British journal of clinical pharmacology Pub Date : 2025-05-30 DOI:10.1002/bcp.70115

Ramesh Sharma Poudel, Sabrina J M Burer, Kylie A Williams, Lisa G Pont

{"title":"Validity of the Medication Safety Self-Assessment for Long-Term Care tool in Australian long-term care: a RAND appropriateness method study.","authors":"Ramesh Sharma Poudel, Sabrina J M Burer, Kylie A Williams, Lisa G Pont","doi":"10.1002/bcp.70115","DOIUrl":null,"url":null,"abstract":"Aims: The validity of using the Canadian Medication Safety Self-Assessment for Long-Term Care (MSSA-LTC) tool in the international context is unknown. This study aims to determine the face and content validity of the Canadian MSSA-LTC tool for assessing medication safety-related processes in the Australian long-term care (LTC) setting.Methods: A modified two-round RAND/UCLA Appropriateness Method was used to assess the face and content validity of the 129 items in the Canadian MSSA-LTC tool for use in the Australian LTC setting. An expert panel of health professionals with expertise in medication management in the Australian LTC setting rated each item separately for relevance to the Australian LTC context (face validity) and importance for medication safety (content validity). Items, where there was panel agreement that the item was definitely or potentially relevant for the Australian context/important for medication safety, were considered valid for the relevant attribute.Results: Nine expert panel members participated in the study. The expert panel rated 118 (91.5%) of the 129 items of the MSSA-LTC tool as acceptable relevant for the Australian LTC setting and, therefore, having face validity and all items (100%) as important for medication safety, thus having good content validity. The expert panel members were unable to agree about the relevance of nine items for use in the Australian LTC context and considered two items as not relevant for the Australian LTC context.Conclusions: The Canadian MSSA-LTC tool appears valid for measuring medication safety-related processes in Australian LTC with good face and content validity.","PeriodicalId":9251,"journal":{"name":"British journal of clinical pharmacology","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British journal of clinical pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/bcp.70115","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}

引用次数: 0

Abstract

Aims: The validity of using the Canadian Medication Safety Self-Assessment for Long-Term Care (MSSA-LTC) tool in the international context is unknown. This study aims to determine the face and content validity of the Canadian MSSA-LTC tool for assessing medication safety-related processes in the Australian long-term care (LTC) setting.

Methods: A modified two-round RAND/UCLA Appropriateness Method was used to assess the face and content validity of the 129 items in the Canadian MSSA-LTC tool for use in the Australian LTC setting. An expert panel of health professionals with expertise in medication management in the Australian LTC setting rated each item separately for relevance to the Australian LTC context (face validity) and importance for medication safety (content validity). Items, where there was panel agreement that the item was definitely or potentially relevant for the Australian context/important for medication safety, were considered valid for the relevant attribute.

Results: Nine expert panel members participated in the study. The expert panel rated 118 (91.5%) of the 129 items of the MSSA-LTC tool as acceptable relevant for the Australian LTC setting and, therefore, having face validity and all items (100%) as important for medication safety, thus having good content validity. The expert panel members were unable to agree about the relevance of nine items for use in the Australian LTC context and considered two items as not relevant for the Australian LTC context.

Conclusions: The Canadian MSSA-LTC tool appears valid for measuring medication safety-related processes in Australian LTC with good face and content validity.

查看原文本刊更多论文

长期护理用药安全自我评估工具在澳大利亚长期护理中的有效性：一项RAND适宜性方法研究。

目的：加拿大长期护理用药安全自我评估（MSSA-LTC）工具在国际范围内的有效性尚不清楚。本研究旨在确定加拿大MSSA-LTC工具在澳大利亚长期护理（LTC）环境中评估药物安全相关过程的表面效度和内容效度。方法：采用一种改进的两轮RAND/UCLA适当性方法来评估加拿大MSSA-LTC工具中129个项目的外观和内容效度，以供澳大利亚LTC设置使用。一个由具有澳大利亚长期临床研究背景下药物管理专业知识的卫生专业人员组成的专家小组，分别根据与澳大利亚长期临床研究背景的相关性（表面效度）和对药物安全的重要性（内容效度）对每个项目进行评级。如果专家组一致认为该项目与澳大利亚环境明确或潜在相关/对药物安全很重要，则被认为是有效的相关属性。结果：9名专家小组成员参与了研究。专家小组将MSSA-LTC工具的129个项目中的118个（91.5%）评为与澳大利亚LTC设置相关的可接受项目，因此具有表面效度，所有项目（100%）对药物安全都很重要，因此具有良好的内容效度。专家小组成员无法就9个项目是否适用于澳大利亚LTC背景达成一致意见，并认为有2个项目与澳大利亚LTC背景不相关。结论：加拿大msa -LTC工具在澳大利亚LTC中具有良好的表面效度和内容效度，可有效地测量药物安全相关过程。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

British journal of clinical pharmacology 医学-药学

CiteScore

6.30

自引率

8.80%

发文量

419

审稿时长

1 months

期刊介绍： Published on behalf of the British Pharmacological Society, the British Journal of Clinical Pharmacology features papers and reports on all aspects of drug action in humans: review articles, mini review articles, original papers, commentaries, editorials and letters. The Journal enjoys a wide readership, bridging the gap between the medical profession, clinical research and the pharmaceutical industry. It also publishes research on new methods, new drugs and new approaches to treatment. The Journal is recognised as one of the leading publications in its field. It is online only, publishes open access research through its OnlineOpen programme and is published monthly.